Labshake search
Citations for R&D Systems :
1101 - 1150 of 2792 citations for Recombinant Mouse EFNA4 Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2021Quote: ... TNFα and IL-6 in supernatants were measured using ELISAs (Mouse TNFα; Mouse CCL5; Mouse IL-6, R&D Systems) according to the manufacturer’s protocols ...
-
bioRxiv - Developmental Biology 2021Quote: ... Explants were either treated with recombinant FST (7.5 μg/ml, Cat no. 769-FS-025, R&D Systems) or anti-FST antibody (20 μ/ml ...
-
bioRxiv - Immunology 2021Quote: ... Macrophages and neutrophils were primed where indicated with recombinant murine IFN-g (50 ng/ml, R&D Systems) for 1 hour (for neutrophil cultures ...
-
bioRxiv - Immunology 2019Quote: ... Following an overnight culture islets were treated with 200 U/ml recombinant human (h) TNFα (R&D Systems) for 1 ...
-
bioRxiv - Immunology 2019Quote: ... and antibodies were obtained as follows: recombinant human VCAM-1 (#862-VC) from R&D Systems (Minneapolis, MN); recombinant human IL-2 from the NIH AIDS Reagent Program ...
-
bioRxiv - Molecular Biology 2020Quote: ... A mix of recombinant 10 ng/ml IL6 or IL6/IL6R complexes (R&D Systems, Minneapolis, MN, USA), with or without EVs ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human PRDX6 (150 μg/mL final) and active MAPK (ERK2, R&D Systems, 10 μg/mL final) were added to 30 μL of a phosphorylation buffer containing 50 mM Tris/HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2022Quote: ... Microvessels with and without 24 h treatment with 5 ng mL-1 human recombinant TNFα (R&D Systems), were perfused with THP1s under low shear stress (∼0.2 dyne cm-2 ...
-
bioRxiv - Bioengineering 2022Quote: ... media in the top compartment was replaced with recombinant human TNFα (0.1 ng/mL, R&D Systems, 210TA) and recombinant human IFNγ (2 IU/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... the beads were introduced to either 20 nM recombinant human GAS6 (R&D Systems, Cat# 885-GSB-050), or recombinant human Protein S (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... then incubated with various concentrations (0 to 100 nM) of human recombinant tau (2N4R, R&D Systems Inc.) in the absence or presence of RAP (at a 20-fold molar excess compared to the concentration of tau ...
-
bioRxiv - Genomics 2019Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells were incubated for 8 hours prior to harvest ...
-
bioRxiv - Cell Biology 2022Quote: ... or Basal Medium plus 100 ng/ml recombinant human NTN1 (6419-N1, R&D Systems, Minneapolis, MI, USA). Photographs were taken after 4 h of incubation ...
-
bioRxiv - Biochemistry 2019Quote: ... These wells were suspended above wells containing 5 to 10 ng/mL recombinant human VEGF (R&D Systems) or full serum medium ...
-
bioRxiv - Cell Biology 2019Quote: ... Control medium was then augmented with 10 ng/mL recombinant human TGF-β1 (R&D Systems; chondrogenic media) to induce chondrogenesis ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Genomics 2020Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells incubated for 8 hours prior to harvest.
-
bioRxiv - Immunology 2020Quote: ... and cultured for 6 days with recombinant GM-CSF (R&D Systems cat. 215-GM, 50 ng/ml) and IL-4 (R&D Systems cat ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Developmental Biology 2024Quote: ... we pre-treated 1 mL of FBS with 2.5 mg of recombinant human ALK1-Fc (R&D systems) and rocked at room temperature for 2 hours before adding to 49 mL EGM2 for a final concentration of 50 µg/mL ALK1-Fc ...
-
bioRxiv - Immunology 2024Quote: ... was used according to manufacturer instructions or pericytes were directly exposed to recombinant m-MCP6 (R&D systems, matured according to manufacturer instructions ...
-
bioRxiv - Molecular Biology 2023Quote: Control and Slc7a7-/- mice were intraperitoneally injected with recombinant human erythropoietin (500 U/kg/day; R&D Systems) daily for three consecutive days ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 complex was made with 1.5μg of recombinant human IL-2 (NIH) and 7.5μg of anti-human IL-2 (R&D Systems) per injection in 100μL of sterile PBS ...
-
bioRxiv - Biophysics 2023Quote: ... 10 ng/mL recombinant human transforming growth factor beta 1 (TGF-β1 from R&D System, Minnesota, USA). For 3D cultures ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were treated for 24h with 100ng/ml media of human recombinant GBA (rhGBA-His (R&D Systems)).
-
bioRxiv - Cancer Biology 2023Quote: ... C2C12 cells were treated with ZA in the presence or absence of recombinant human TGFβ1 (R&D Systems).
-
bioRxiv - Cell Biology 2023Quote: ... EBs were formed in an ESC medium depleted of recombinant human FGF-2 (rhFGF-2) (R&D Systems) on day 0 ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/mL heregulin-1β (recombinant human NRG-β 1/HRG-β1 EGF domain; R&D Systems, USA), 200 ng/mL recombinant human IGF-1 (LONG R3-IGF-1 ...
-
bioRxiv - Immunology 2023Quote: PBMC were isolated from whole blood and treated with recombinant human CCL2 (279-MC-010; R&D Systems) at 100 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... were coated with 100 μl per well of 1.5 μg/ml human recombinant integrin αvβ6 (R&D Systems) diluted in coating buffer from the ELISA Starter Accessory Kit (Bethyl Laboratories ...
-
bioRxiv - Microbiology 2023Quote: ... Cells were pretreated with vehicle or 50 ng/mL recombinant human IL-8 (rhIL-8, R&D Systems) 12 h before scratch assay ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant BMP-4 (R&D Systems) and 20 ng/mL human recombinant FGF-4 (R&D Systems) ...
-
bioRxiv - Cell Biology 2024Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Immunology 2024Quote: ... NK cells were cultured in RP10 supplemented with 300 IU/ml recombinant human IL-2 (R&D Systems) for 72 h unless otherwise noted ...
-
bioRxiv - Bioengineering 2024Quote: ... This was done by incubating 100 µg of recombinant human G-CSFR (381-GR/CF, R&D Systems) in 950 µL PBS for 2 h at room temperature (RT ...
-
bioRxiv - Immunology 2024Quote: ... or CEFTA were supplemented with 10IU/mL of recombinant human IL-2 (rh IL-2; R&D Systems) and 10ng/mL of recombinant human IL-7 (rh IL-7 ...
-
bioRxiv - Bioengineering 2023Quote: ... either 5μg or 2.5μg of the S protein or NC protein (R&D Systems, cat# 10474-CV-050 and cat# 10549-CV-100) ...
-
bioRxiv - Physiology 2021Quote: ... either in the absence or presence of increasing concentrations of recombinant NMB (0.1-100 nM R&D systems GmBH) 500 μM carbachol,a cholinomimetic agonist ...
-
bioRxiv - Neuroscience 2020Quote: ... Primary neurons and EVs were pre-incubated with active recombinant human CD59 (cat. no. 1987-CD, R&D Systems) at a final concentration of 1 μM (stock at 10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... except for pre-crossing cultures where the medium was supplemented with recombinant Netrin (50 ng/ml, R&D Systems). Primary neurons were plated at low density (8’000-10’000 cells/well ...
-
bioRxiv - Microbiology 2021Quote: ... with 10% FBS (Wisent) and 0.5 ng/ml recombinant human Macrophage Colony Stimulating factor (M-CSF) (R&D Systems) to allow for differentiation of monocytes into macrophages ...
-
bioRxiv - Physiology 2021Quote: ... The medium was supplemented with 100 ng/mL recombinant human M-CSF using CellXVivo™ kit (R&D Systems) and differentiated for 5–7 days prior to use.
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with 10 ng ml−1 of recombinant human IFNγ (R&D Systems, 285-IF-100), 10 ng ml−1 of recombinant human TNFα (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... T cells then were washed and further incubated with recombinant human IL-2 (10 ng/ml; R&D systems) for up to 2 weeks at 37°C incubator with medium change every 3 days ...
-
bioRxiv - Molecular Biology 2022Quote: ... human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF, 50 ng/mL R&D Systems, 7954-GM-020/CF), and interleukin-4 (IL-4 ...
-
bioRxiv - Immunology 2020Quote: Primary murine B cells were incubated in 20 mM β-lactose or 0.1 μM recombinant Gal9 (R&D systems) in RPMI1640 at 37°C for 30 minutes ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human galectin-4 (GAL4 P56470) and gelsolin (GSN Q3SX14) from bovine plasma were purchased from R&D Systems and Sigma respectively.
-
bioRxiv - Cell Biology 2021Quote: ... NKG2DLs expression in each cancer cell line was stained with recombinant human NKG2D Fc chimera (R&D Systems, USA) and then FITC-conjugated anti-human Fc secondary antibody was used as a detection antibody (BD Biosciences ...
-
bioRxiv - Developmental Biology 2022Quote: ... Explants were either treated with recombinant BMP2/7 heterodimers (32 nM, R&D Systems, Cat No. 3229-BM-010) or Noggin (300 ng/μl ...